Tailored antisense oligonucleotides (ASOs) are changing the future of rare genetic disease therapies Published On 16 April 2025 In Biology Rare diseases affect hundreds of millions worldwide, with most cases having genetic origins and primarily impacting chil... By Editorial Staff
